Antibody-Based Therapies for Cutaneous T-Cell Lymphoma Antibody-Based Therapies for Cutaneous T-Cell Lymphoma

Monoclonal antibody therapies, such as alemtuzumab, brentuximab vedotin, and mogamulizumab, are showing promise for previously relapsed and refractory CTCL.American Journal of Clinical Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news